Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. EBITDA

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 20254,723+37.62%
Mar 31, 20243,432-20.19%
Mar 31, 20234,300-0.58%
Mar 31, 20224,325-19.44%
Mar 31, 20215,369-1.92%
Mar 31, 20205,474+21.48%
Mar 31, 20194,506+24.06%
Mar 31, 20183,632-10.94%
Mar 31, 20174,078-0.85%
Mar 31, 20164,113+41.83%
Mar 31, 20152,900

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)